Omair Ahmed - Echo Health Ventures

New York, NY

Omair is a Principal at Echo Health Ventures actively involved in sourcing, analyzing, structuring and executing new investments, as well as supporting the growth and success of Echo's portfolio companies. His investment focus spans digital health, health care IT, and tech-enabled services, with particular interest in businesses innovating pharmacy benefit models, partnering with self-insured employers to drive meaningful outcomes, and reimagining how clinical and benefit models are designed and delivered.

Omair currently serves as a Board Observer for Abacus Insights, Ideon, Scipher Medicine, and Vori Health. He also works closely with Echo’s investments in Lantern and Thyme Care, and has supported companies including VaxCare (acquired by Blackstone), Waltz Health (acquired by Eversana), and Care Connectors Medical Group. Omair previously held roles as a Board Observer on Embold Health (acquired by Quantum Health) and Springbuk (acquired by Merative).

Prior to joining Echo, Omair began his career as a consultant for Accenture Strategy, advising health care clients on go-to-market, new product development, and merger strategies. He also brings experience in health care-focused venture capital through his prior roles at Merck’s Global Health Innovation Fund and 7Wire Ventures.

Omair received a bachelor’s degree with honors from New York University’s Stern School of Business, and a Master of Business Administration degree with distinction from Northwestern University’s Kellogg School of Management.

Omair is based out of New York City.

Latest Posts

Innovation and Opportunities for Investors to Address Social Drivers of Health

Omair Ahmed, a Strategic Investment Associate with Echo Health Ventures, shares thoughts on how investors can address inequities within health care.

View All Posts